Tennor Therap-b
Status: Publicly traded
Direct answer
Tennor Therap-b is publicly traded on HKSE under the ticker 6872.HK.
TenNor Therapeutics (Suzhou) Limited specializes in researching, developing, and bringing to market unique therapies for illnesses arising from bacterial infections and bacterial metabolic functions. Its robust product pipeline includes Rifasutenizole (TNP-2198), designed to combat Helicobacter pylori infections. Another key asset, Rifaquizinone (TNP-2092), is being advanced in an injectable formulation to treat...
Can you invest in Tennor Therap-b?
Yes. Tennor Therap-b trades publicly on HKSE as 6872.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Tennor Therap-b
Detailed equity research is provided by MarketSnap.